Insight Molecular Diagnostics (IMDX) EBT Margin (QoQ) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.30 Mn |
| Dec 31, 2025 | 85,745.00 |
| Sep 30, 2025 | -131,643.00 |
| Jun 30, 2025 | -126,156.00 |
| Mar 31, 2025 | 191,584.00 |
| Dec 31, 2024 | 544,439.00 |
| Sep 30, 2024 | -273,089.00 |
| Jun 30, 2024 | 19,174.00 |
| Mar 31, 2024 | -9,394.00 |
| Dec 31, 2023 | -358,041.00 |
| Sep 30, 2023 | 28,720.00 |
| Jun 30, 2023 | -380,618.00 |
| Mar 31, 2023 | 230,765.00 |
| Dec 31, 2022 | 241,218.00 |
| Sep 30, 2022 | -213,791.00 |
| Jun 30, 2022 | -24,861.00 |
| Mar 31, 2022 | 67,024.00 |
| Dec 31, 2021 | 40,528.00 |
| Sep 30, 2021 | -79,717.00 |
| Jun 30, 2021 | 41,635.00 |